Skip to main content

Table 3 Expression of FABP7 and EGFR mRNA in GBM from two independent published DNA microarray datasets

From: Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma

Dataset 1 (ref. 29)

Dataset 2(ref. 30)

Case #

FABP7

EGFR

Case #

FABP7

EGFR

47.0

227.5

763.5

1375

28.8

233.8

210.4

337.0

1113.8

276

1010.0

775.2

193.0

555.6

831.6

519

72.1

46.7

21.7

974.6

471.4

368

418.2

14.7

97.3

1277.9

146.0

157

6.3

35.2

147.9

1384.4

188.3

1162

378.0

139.9

365.0

1758.1

625.4

1644

9.8

165.8

131.7

1908.4

367.4

406

950.8

341.8

459.4

2126.0

1522.5

308

611.3

473.7

33.9

2246.2

2588.0

177

817.8

630.8

58.7

2250.7

558.9

103

313.2

74.4

158.0

2289.3

327.5

992

1024.3

842.2

22.3

2351.9

224.2

41

952.3

56.6

97.9

2480.0

578.6

1354

101.3

182.9

14.0

2662.4

1134.1

308

424.0

169.2

205.9

2746.3

357.6

408

279.7

97.3

232.0

3071.7

220.9

242

1137.2

673.9

226.6

3190.2

547.5

323

218.8

208.4

29.4

3944.2

196.8

213

219.6

49.0

68.0

4158.9

3010.9

97

352.8

87.4

5.3

4496.3

625.6

281

978.6

357.0

31.1

4831.9

7883.7

501

1166.7

64.5

83.0

5120.5

1440.0

670

461.1

444.7

80.0

5508.2

2871.1

729

1711.5

8.9

82.0

5854.7

741.7

21

1690.3

2057.1

103.6

6008.9

9373.4

630

353.7

274.0

2.6

6850.0

3259.5

263

460.3

375.6

41.3

7593.1

441.2

219

486.4

179.7

60.9

7966.5

7258.6

   

46.1

8795.5

284.8

   

40.3

8946.3

410.0

   

58.3

11070.1

3518.5

   

50.4

11956.1

10788.3

   

16.3

13108.3

6798.5

  Â